Import Alert 66-66: APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122
66-66: APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122. Dated 744 days ago, it serves as a historical benchmark. Score 35/100. As of 2026-11-03, from U.S. FDA Import Alerts (accessdata.fda.gov).
Data as of · Compiled by Zalwin from U.S. FDA Import Alerts (accessdata.fda.gov)
Free preview: all 5 published fields of this record are shown below. Locked: 17 related FdaImportAlertPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Alert number | 66-66 |
| Name | APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122 |
| Industry | Drugs & biologics |
| Type | DWPE |
| Last published | 2024-10-22 |
| Peer records CSV (18 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch 66-66
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock 66-66 + all 18 records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Alert · Name · Industry · Type · Last published · official source URL
- Source agency: U.S. FDA Import Alerts (accessdata.fda.gov)
- Record date: 2024-10-22
- Data refreshed: 2026-11-03
- Refunds on request within 14 days
LIVE PUBLIC DATA Source: U.S. FDA Import Alerts (accessdata.fda.gov) · Last refreshed: Tue, 03 Nov 2026 19:38:30 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: 66-66 and 18 drugs peers
- drugs FdaImportAlertPulse records like this one: 18
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every drugs peer: $3,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
35 / 100 Compliance Urgency Score
- Detention without physical examination.
What is the FdaImportAlertPulse record for 66-66?
FDA Import Alert 66-66 (DWPE, Drugs & biologics) was last published 2024-10-22: APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122.
How does 66-66 compare to other FdaImportAlertPulse records?
It is 744 days old; check the official source for later updates before acting. Its Compliance Urgency Score of 35/100 is modest; treat it as background rather than a priority.
66-66 vs. top 3 peers
Related records
FdaImportAlertPulse: Drugs & biologics FdaImportAlertPulse: DWPE
How to monitor 66-66 and peer dwpe records
Get new FdaImportAlertPulse records like 66-66 by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get import alert updates for your categories
FdaImportAlertPulse emails when an import alert in your industry is published or updated.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From FDA's published import alert list; the FDA alert page (linked) is authoritative and lists the firms and products covered. Informational only, not regulatory advice.